Eli Lilly hits record high as healthcare stocks rally

AbbVie

Yesterday 15:24

**  Shares of the world's largest drugmaker Eli Lilly LLY.N jump 5.45% to an all-time high of $1,307.91 
** Stock's previous 52-week high was $1,292.65
** Wall Street coverage on the trillion-dollar stock tilts bullish with 29 analysts rating it "buy" or "strong buy", 3 rating "hold" and 1 "sell" with a median PT of $1,380.50, per LSEG data
** LLY has broadened its drug pipeline through a series of acquisitions and licensing deals, using the strong cash flow from its diabetes and weight-loss medicines to fuel a wider dealmaking push
** Other large-cap drugmakers including Amgen AMGN.O, Pfizer PFE.N, Johnson & Johnson JNJ.N and AbbVie  ABBV.N were also up in morning trade, the broader S&P 500 Healthcare Index .SPXHC touched a record high  
** Including session's move, LLY stock was up ~21% YTD 

 (Reporting by Padmanabhan Ananthan)
 ((Padmanabhan.Ananthan@thomsonreuters.com))